Medication adherence and needs among patients with schizophrenia in China: a qualitative study
Clicks: 22
ID: 309731
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
6.3
/100
22 views
10 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #442 of 442 articles by views in BMJ open
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 442 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objectives To explore the factors influencing medication adherence and the medication needs of patients with schizophrenia when living in a community in China. Design A qualitative study. Setting Community and psychiatric ward in Zhuhai city, Guangdong province. Participants Patients with schizophrenia and (or) their primary caregivers. Primary and secondary outcome measures Facilitators and barriers of medication adherence and the medication needs. Results A total of 20 patients with schizophrenia and 12 primary caregivers participated in the study. Based on the Health Ecology Model, the analysis identified four levels of factors influencing medication adherence, categorised as individual (facilitators: effective treatment, positive expectation, establishing a routine and assistive tools; barriers: side effects, inadequate knowledge, forgetfulness and irregular daily schedule), interpersonal (facilitators: caregiver assistance and psychiatrist’s recommendation; barriers: lack of social support), community (facilitators: community mental health services and reducing medication use frequency; barriers: limited medication accessibility and affordability) and policy and culture related (facilitators: collectivist culture and social security policy; barriers: stigma). Additionally, five medication needs (managing side effects, applying for social security, improving medication accessibility, transitioning to long-acting injections and getting health education) were recognised. Conclusions These findings offer valuable insights for healthcare providers and policymakers, underscoring the need for targeted interventions to enhance medication adherence among patients with schizophrenia in China.
| Reference Key |
xuping2025medicationadherencea
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Xuping Li; Shuiyuan Xiao; Yajun Sun; Ying Zheng; Jiaju Huang; Ning Wei; Chun Mao; Shengjun Zhang; Yongyong Teng |
| Journal | BMJ open |
| Year | 2025 |
| DOI |
10.1136/bmjopen-2024-092073
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.